Income favouriteGlaxoSmithKline (LSE: GSK) has finalised its impressively ambitious three-part deal with Swiss giant Novatis, and thusitsshareholders cannow look forward toa 4 billion cash return.
To find out the strategies to adopt if you want tobecome one of the growing number of surprise UK millionaires, read this FREE Motley Fool report:’7 Simple Steps For Seeking Serious Wealth‘ while it remains available!
Owain Bennallackowns shares in GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.